Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction-Reference-Cited by-同舟云学术

Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction

Published:2015-03-23 Issue:10 Volume:101 Page:800-807
ISSN:1355-6037
Container-title:Heart
language:en
Short-container-title:Heart

Author:

Shore Supriya,Jones Philip G,Maddox Thomas M,Bradley Steven M,Stolker Joshua M,Arnold Suzanne V,Parashar Susmita,Peterson Pamela,Bhatt Deepak L,Spertus John,Ho P Michael

Publisher

BMJ

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association;Smith;J Am Coll Cardiol,2011

2. The influence of risk status on guideline adherence for patients with non-ST-segment elevation acute coronary syndromes;Roe;Am Heart J,2006

3. Changes in myocardial infarction guideline adherence as a function of patient risk: an end to paradoxical care?;Motivala;J Am Coll Cardiol,2011

4. The Prospective Registry Evaluating Myocardial Infarction: Events and Recovery (PREMIER)—evaluating the impact of myocardial infarction on patient outcomes;Spertus;Am Heart J,2006

5. Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients’ Health Status (TRIUMPH): design and rationale of a prospective multicenter registry;Arnold;Circ Cardiovasc Qual Outcomes,2011

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction;New England Journal of Medicine;2024-04-18

2. Prescribing Trends of Renin-Angiotensin System Inhibitors and Mortality among Acute Coronary Syndrome Patients: Insights from the Malaysian National Cardiovascular Disease Registry;Saudi Journal of Medicine & Medical Sciences;2024-04

3. Patient Adherence to Secondary Prevention Therapies After an Acute Coronary Syndrome: A Scoping Review;Clinical Therapeutics;2023-11

4. Long-term lifestyle change and risk of mortality and Type 2 diabetes in patients with cardiovascular disease;European Journal of Preventive Cardiology;2023-09-29

5. βeta blocker interruption after uncomplicated myocardial infarction: rationale and design of the randomized ABYSS trial;American Heart Journal;2023-04